YANGZHOU, China, Oct. 7, 2024
/PRNewswire/ -- Meihua International Medical Technologies Co., Ltd.
("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer
and provider of Class I, II, and III disposable medical devices
with operating subsidiaries in China, today announced that on October 3, 2024, it received a notification
letter (the "Notification Letter") from the Listing Qualifications
Department of the Nasdaq Stock Market LLC ("Nasdaq"), informing the
Company that it has regained compliance with the minimum bid price
requirement set forth in Nasdaq Listing Rule 5450(a)(1) (the
"Minimum Bid Price Requirement").
As previously reported, the Company was notified on April 2, 2024, that its ordinary shares failed to
maintain a minimum bid price of $1.00
over the previous 30 consecutive business days as required by the
Nasdaq Minimum Bid Price Requirement.
Since then, Nasdaq has determined that for the last 21
consecutive business days, from September 4,
2024 to October 2, 2024, the
closing bid price of the Company's Ordinary Shares has been at
$1.00 per share or greater.
Accordingly, the Company has regained compliance with Listing Rule
5450(a)(1), and the matter is now closed.
About Meihua International Medical Technologies Co.,
Ltd.
Meihua International Medical Technologies Co., Ltd. is a
reputable manufacturer and provider of Class I, II and III
disposable medical devices with operating subsidiaries in
China. The Company manufactures
and sells Class I disposable medical devices, such as HDPE bottles
for tablets and LDPE bottles for eye drops, throat strips, and anal
bags, and Class II and III disposable medical devices, such as
disposable identification bracelets, gynecological examination
kits, inspection kits, surgical kits, medical brushes, medical
dressing, medical catheters, uterine tissue suction tables, virus
sampling tubes, disposable infusion pumps, electronic pumps and
anesthesia puncture kits, among other products which are sold under
the Company's own brands and are also sourced and distributed from
other manufacturers. The Company has received an international "CE"
certification and ISO 13485 system certification and has also
registered with the FDA (registration number: 3006554788) for over
20 Class I products. The Company has served hospitals, pharmacies,
medical institutions and medical equipment companies for more than
30 years, providing over 1,000 types of products for domestic
sales, as well as over 120 products which are exported to more than
30 countries internationally across Europe, North
America, South America,
Asia, Africa and Oceania.
For more information, please visit www.meihuamed.com.
Follow us on Webull:
https://www.webull.com/quote/nasdaq-mhua.
For investor and media inquiries, please contact:
IR Department
Email: secretary@meihuamed.com
Tel: +86-0514-89800199
Christensen
Yang Song
Email: yang.song@christensencomms.com
Tel: +86-010-59001548
View original
content:https://www.prnewswire.com/news-releases/meihua-international-medical-technologies-co-ltd-regains-compliance-with-nasdaq-minimum-bid-price-requirement-302268608.html
SOURCE Meihua International Medical Technologies Co., Ltd.